BOROSCI — Borosil Scientific Income Statement
0.000.00%
- IN₹12.54bn
- IN₹11.58bn
- IN₹4.38bn
- 82
- 28
- 28
- 42
Annual income statement for Borosil Scientific, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | PRESS |
Standards: | IAS | — |
Status: | Final | Final |
Revenue | ||
Total Revenue | 3,946 | 4,385 |
Cost of Revenue | ||
Gross Profit | 1,824 | 2,770 |
Selling / General / Administrative Expenses | ||
Depreciation and Amortization | ||
Unusual Expense / Income | ||
Other Operating Expenses | ||
Total Operating Expenses | 3,656 | 4,044 |
Operating Profit | 290 | 341 |
Gain / Loss on Sale of Assets | ||
Total Net Non Operating Interest Income / Expense | ||
Other Net Non Operating Costs | ||
Net Income Before Taxes | 316 | 404 |
Provision for Income Taxes | ||
Net Income After Taxes | 235 | 267 |
Minority Interest | ||
Net Income Before Extraordinary Items | ||
Net Income | 236 | 268 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | 236 | 268 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | 2.66 | 3.02 |